Thermo Fisher Scientific continues to provide the gold standard of testing with our evolved, PCR-based TaqPath RNase P Combo Kit 2.0 test, which was established to help laboratories quickly diagnose COVID-19 caused by SARS-CoV- 2 infection.
TaqPath RNase P Combo Kit 2.0 was developed with an advanced, multi-target assay design and RNase P control for human sample confirmation.
TaqPath COVID-19 RNase P Combo Kit 2.0—Now available!
- Recommended for use with RNA extracted from nasopharyngeal and anterior nasal swabs
- Detects active infections from individuals suspected of COVID-19 by their healthcare provider, as well as asymptomatic individuals
- Utilizes human sample confirmation RNase P gene as an internal control
- Go from sample to result in ~3 hours
Fill out the form, and a sales representative will be in touch.